PRESS RELEASE

CELLECTIS has choosen ACCELERA as the preferred partner to provide the preclinical studies for UCART19
*******
Download  full  announcement

To know more about the agreement
Karolinska Development / Accelera

Click Here
************************

Do you have a Drug Candidate
to move to Clinics?

Accelera helps you
contact  us

Join us at EUROTOX


ACCELERA PRESENTATION
visit BOOTH # 14

Edimburgh, UK
7-10 September, 2014





 

Join us at AFI
Symposium

ACCELERA PRESENTATION
POSTER AWARDED

Rimini, Italy - June 11-13, 2014
Click here to know more